Literature DB >> 2419157

Localisation of the main immunogenic region of the nicotinic acetylcholine receptor.

T Barkas, J M Gabriel, M Juillerat, A Kokla, S J Tzartos.   

Abstract

The nicotinic acetylcholine receptor from Torpedo marmorata was digested using papain and the reaction products separated by SDS gel electrophoresis and characterised by immunoblotting using labelled alpha-bungarotoxin, polyclonal antibodies to synthetic peptides and monoclonal antibodies to the main immunogenic region (MIR). Using this approach, it was possible to show that the MIR is located N-terminal to all or part of peptide 151-169 (peptide P1) of the alpha-chain and that papain cleaves the alpha-chain between Asn 141 and peptide P1.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2419157     DOI: 10.1016/0014-5793(86)80254-x

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

Review 1.  The main immunogenic region (MIR) of the nicotinic acetylcholine receptor and the anti-MIR antibodies.

Authors:  S J Tzartos; M T Cung; P Demange; H Loutrari; A Mamalaki; M Marraud; I Papadouli; C Sakarellos; V Tsikaris
Journal:  Mol Neurobiol       Date:  1991       Impact factor: 5.590

2.  Action of antibodies directed against the acetylcholine receptor on channel function at mouse and rat motor end-plates.

Authors:  J O Dolly; M Gwilt; G Lacey; J Newsom-Davis; A Vincent; P Whiting; D W Wray
Journal:  J Physiol       Date:  1988-05       Impact factor: 5.182

3.  Antigenic role of single residues within the main immunogenic region of the nicotinic acetylcholine receptor.

Authors:  I Papadouli; S Potamianos; I Hadjidakis; E Bairaktari; V Tsikaris; C Sakarellos; M T Cung; M Marraud; S J Tzartos
Journal:  Biochem J       Date:  1990-07-01       Impact factor: 3.857

4.  Identification of T-cell epitopes of autoantigens using recombinant proteins; studies on experimental autoimmune myasthenia gravis.

Authors:  Y Zhang; S Frutiger; G J Hughes; M C Savoy; T Barkas
Journal:  Immunology       Date:  1990-12       Impact factor: 7.397

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.